On December 31, 2018, Mark R. Tobin resigned from his position as a director of Innovation Pharmaceuticals Inc., effective immediately. Given the increased demands of his full-time job, Mr. Tobin does not have the time necessary to devote to the Company to fill the position of director. On January 7, 2019, Arthur P. Bertolino the Company’s President and Chief Medical Officer, joined the Board of Directors.